TABLE 2.

Percentages of embryos with abnormal phenotypes among the surviving injected embryos^a

Injected material and expt no	No. of embryos			% of embryos with abnormal phenotype
	Injected	With fluorescence	With abnormal phenotype	In each expt	Avg ± SD for group
pcXGFP					0
1	199	121	0	0
2	189	107	0	0
3	167	98	0	0
pG48R					53.58 ± 0.89
1	59	32	32	54.2
2	89	48	48	53.9
3	78	41	41	52.6
pGV121					45.53 ± 1.93
1	194	84	84	43.3
2	146	68	68	46.6
3	152	71	71	46.7
pG48R plus pGV121					74.70 ± 1.82
1	98	72	72	73.5
2	112	86	86	76.8
3	107	79	79	73.8

^aThe embryos were at the stage of 48 hpf. The data shown here were collected from three individual injection experiments. The embryos were injected at the one-cell stage. Approximately 0.15 to 0.2 ng of pcXGFP, pG48R, pGV121, and pG48R plus pGV121 was injected in each embryo.